Free Trial
CVE:NDVA

Indiva (NDVA) Stock Price, News & Analysis

Indiva logo
C$0.03 -0.01 (-14.29%)
As of 06/12/2024

About Indiva Stock (CVE:NDVA)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.02
C$0.13
Volume
558,384 shs
Average Volume
119,038 shs
Market Capitalization
C$5.86 million
P/E Ratio
N/A
Dividend Yield
4.04%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NDVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter.

NDVA Stock News Headlines

Indiva Ltd (T8RP.BE) - Yahoo Finance
Indiva Ltd Average Daily Volume (3m)
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
Indiva Limited (NDVA-H.V)
NDVA:CA Indiva Limited
Indiva Limited (NDVAF) Q4 2023 Earnings Call Transcript
See More Headlines

NDVA Stock Analysis - Frequently Asked Questions

Indiva's stock was trading at C$0.03 on January 1st, 2025. Since then, NDVA stock has increased by 0.0% and is now trading at C$0.03.

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:NDVA
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.92 million
Net Margins
-13.09%
Pretax Margin
N/A
Return on Equity
-544.76%
Return on Assets
-3.51%

Debt

Debt-to-Equity Ratio
5,899.22
Current Ratio
0.72
Quick Ratio
0.52

Sales & Book Value

Annual Sales
C$37.57 million
Price / Sales
0.16
Cash Flow
C$0.01 per share
Price / Cash Flow
5.20
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
195,490,000
Free Float
N/A
Market Cap
C$5.86 million
Optionable
Not Optionable
Beta
1.12
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (CVE:NDVA) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners